My bookmarksSign up free
Source

2009/866/EC: Commission Decision of 30 November 2009 authorising the placing on the market of products containing, consisting of, or produced from genetically modified maize MIR604 (SYN-IR6Ø4-5) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (notified under document C(2009) 9399) (Text with EEA relevance)

2009/866/EC: Commission Decision of 30 November 2009 authorising the placing on the market of products containing, consisting of, or produced from genetically modified maize MIR604 (SYN-IR6Ø4-5) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (notified under document C(2009) 9399) (Text with EEA relevance)

Regulation (EC) No 1829/2003 · Decision · 9 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Genetically modified organism and unique identifier

Article 1

Open ↗

Genetically modified maize ( Zea mays L.) MIR604, as specified in point (b) of the Annex to this Decision, is assigned the unique identifier SYN-IR6Ø4-5, as provided for in Regulation (EC) No 65/2004.

Authorisation

Article 2

Open ↗

The following products are authorised for the purposes of Articles 4(2) and 16(2) of Regulation (EC) No 1829/2003 in accordance with the conditions set out in this Decision: (a) foods and food ingredients containing, consisting of, or produced from SYN-IR6Ø4-5 maize; (b) feed containing, consisting of, or produced from SYN-IR6Ø4-5 maize; (c) products other than food and feed containing or consisting of SYN-IR6Ø4-5 maize for the same uses as any other maize with the exception of cultivation.

Labelling

Article 3

Open ↗

1.   For the purposes of the labelling requirements laid down in Articles 13(1) and 25(2) of Regulation (EC) No 1829/2003 and in Article 4(6) of Regulation (EC) No 1830/2003, the ‘name of the organism’ shall be ‘maize’. 2.   The words ‘not for cultivation’ shall appear on the label of and in documents accompanying products containing or consisting of SYN-IR6Ø4-5 maize referred to in Article 2(b) and (c).

Monitoring for environmental effects

Article 4

Open ↗

1.   The authorisation holder shall ensure that the monitoring plan for environmental effects, as set out in point (h) of the Annex, is put in place and implemented. 2.   The authorisation holder shall submit to the Commission annual reports on the implementation and the results of the activities set out in the monitoring plan.

Community register

Article 5

Open ↗

The information set out in the Annex to this Decision shall be entered in the Community register of genetically modified food and feed, as provided for in Article 28 of Regulation (EC) No 1829/2003.

Authorisation holder

Article 6

Open ↗

The authorisation holder shall be Syngenta Seeds S.A.S., France, representing Syngenta Crop Protection AG, Switzerland.

Validity

Article 7

Open ↗

This Decision shall apply for a period of 10 years from the date of its notification.

Addressee

Article 8

Open ↗

This Decision is addressed to Syngenta Seeds S.A.S., Chemin de l’Hobit 12, BP 27 — F-31790 Saint-Sauveur — France.

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX (a)   Applicant and Authorisation holder: Name : Syngenta Seeds S.A.S. Address : Chemin de l’Hobit 12, BP 27 — F-31790 Saint-Sauveur — France On behalf of Syngenta Crop Protection AG — Schwarzwaldallee 215 — CH 4058 Basle — Switzerland. (b)   Designation and specification of the products: (1) Foods and food ingredients containing, consisting of, or produced from SYN-IR6Ø4-5 maize; (2) Feed containing, consisting of, or produced from SYN-IR6Ø4-5 maize; (3) Products other than food and feed containing or consisting of SYN-IR6Ø4-5 maize for the same uses as any other maize with the exception of cultivation. The genetically modified SYN-IR6Ø4-5 maize, as described in the application, expresses a modified Cry3A protein which provides protection to certain coleopteran pests ( Diabrotica spp.). A pmi gene, allowing transformed maize cells to utilise mannose as a sole carbon source, was used as a selectable marker in the genetic modification process. (c)   Labelling: (1) For the purposes of the specific labelling requirements laid down in Articles 13(1) and 25(2) of Regulation (EC) No 1829/2003, and in Article 4(6) of Regulation (EC) No 1830/2003, the ‘name of the organism’ shall be ‘maize’; (2) The words ‘not for cultivation’ shall appear on the label of and in documents accompanying products containing or consisting of SYN-IR6Ø4-5 maize referred to in Article 2(b) and (c) of this Decision. (d)   Method for detection: — Event specific real-time PCR based method for the quantification of SYN-IR6Ø4-5 maize, — Validated on seeds by the Community Reference Laboratory established under Regulation (EC) No 1829/2003, published at http://gmo-crl.jrc.ec.europa.eu/statusofdoss.htm, — Reference Material: ERM®-BF423 accessible via the Joint Research Centre (JRC) of the European Commission, the Institute of Reference Materials and Measurements (IRMM) at http://www.irmm.jrc.be/html/reference_materials_catalogue/index.htm (e)   Unique identifier: SYN-IR6Ø4-5. (f)   Information required under Annex II to the Cartagena Protocol on Biosafety to the Convention on Biological Diversity: Biosafety Clearing-House, Record ID: see [ to be completed when notified ]. (g)   Conditions or restrictions on the placing on the market, use or handling of the products: Not required. (h)   Monitoring plan: Monitoring plan for environmental effects conforming with Annex VII to Directive 2001/18/EC. [Link: plan published on the Internet ] (i)   Post market monitoring requirements for the use of the food for human consumption: Not required. Note: links to relevant documents may need to be modified over the time. Those modifications will be made available to the public via the updating of the Community register of genetically modified food and feed.

Other acts of the same type
Council Decision (EU) 2021/1213 of 13 July 2021 on the conclusion, on behalf of the Union, of the Agreement in the form of an Exchange of Letters between the European Union and the Argentine Republic pursuant to Article XXVIII of the General Agreement on Tariffs and Trade (GATT) 1994 relating to the modification of concessions on all the tariff-rate quotas included in the EU Schedule CLXXV as a consequence of the United Kingdom’s withdrawal from the European UnionCouncil Decision (EU) 2021/1234 of 13 July 2021 on the conclusion of the Agreement between the European Union and the Kingdom of Thailand pursuant to Article XXVIII of the General Agreement on Tariffs and Trade (GATT) 1994 relating to the modification of concessions on all the tariff-rate quotas included in the EU Schedule CLXXV as a consequence of the United Kingdom’s withdrawal from the European UnionCommission Decision (EU) 2021/1240 of 13 July 2021 on the compliance of the EU portal and the EU database for clinical trials of medicinal products for human use with the requirements referred to in Article 82(2) of Regulation (EU) No 536/2014 of the European Parliament and of the Council (Text with EEA relevance)Council Decision (CFSP) 2021/1143 of 12 July 2021 on a European Union Military Training Mission in Mozambique (EUTM Mozambique)Council Decision (CFSP) 2021/1144 of 12 July 2021 amending Decision 2014/512/CFSP concerning restrictive measures in view of Russia’s actions destabilising the situation in UkraineCommission Decision (EU) 2021/1364 of 9 July 2021 authorising Poland to apply an extension of certain periods specified in Articles 9, 10 and 11 of Regulation (EU) 2021/267 of the European Parliament and of the Council (notified under document C(2021) 5030) (Only the English text is authentic)Commission Decision (EU) 2021/1125 of 8 July 2021 refusing to include the medicinal product subject to prescription Zinc-D-gluconate in the list of medicinal products that shall not bear the safety features referred to in Article 54, point (o), of Directive 2001/83/EC of the European Parliament and of the Council (Text with EEA relevance)Commission Implementing Decision (EU) 2021/1126 of 8 July 2021 establishing the equivalence of COVID-19 certificates issued by Switzerland to the certificates issued in accordance with Regulation (EU) 2021/953 of the European Parliament and of the Council (Text with EEA relevance)Commission Decision (EU) 2021/1363 of 8 July 2021 authorising Finland to apply an extension of certain periods specified in Articles 2, 16 and 17 of Regulation (EU) 2021/267 of the European Parliament and of the Council (notified under document C(2021) 4976) (only the English text is authentic)Commission Implementing Decision (EU) 2021/1138 of 7 July 2021 approving national plans and amendments thereto, as regards Bulgaria and Romania, for the implementation of the validation systems in accordance with Council Regulation (EC) No 1224/2009 (notified under document C(2021) 5158) (Only the Bulgarian and Romanian texts are authentic)Commission Implementing Decision (EU) 2021/1103 of 5 July 2021 on the recognition of the legal, supervisory and enforcement arrangements of Brazil for derivatives transactions entered into by Brazilian institutions under the regulation of the Central Bank of Brazil as equivalent to certain requirements of Article 11 of Regulation (EU) No 648/2012 of the European Parliament and Council on OTC derivatives, central counterparties and trade repositories (Text with EEA relevance)Commission Implementing Decision (EU) 2021/1104 of 5 July 2021 on the recognition of the legal, supervisory and enforcement arrangements of Canada for derivatives transactions supervised by the Office of the Superintendent of Financial Institutions as equivalent to certain requirements of Article 11 of Regulation (EU) No 648/2012 of the European Parliament and of the Council on OTC derivatives, central counterparties and trade repositories (Text with EEA relevance)

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next